Why in News:
Recently, India participated in the 3rd Arctic Science Ministerial (ASM) and shared plans for research and long-term cooperation in the Arctic Region.
Arctic Region:
The Arctic region comprises the Arctic Ocean and parts of countries such as Canada, Denmark (Greenland), Norway, Russia, USA (Alaska), Finland, Sweden and Iceland.
These countries together form the core of the Arctic Council, an intergovernmental forum.
Headquarter: Tromso,Norway.
Read MoreWhy in News?
Key facts:
About:
Why in news?
The Managing Director of TRIFED recently highlighted the role played by Pradhan Mantri Van Dhan Yojana in changing the rural forest-dwelling tribal economy.
About Pradhan Mantri Van Dhan Yojana:
The Ministry of Tribal Affairs launched Pradhan Mantri Van Dhan Yojana in 2018, under the Forest Rights Act of 2005.
Implementation:
Key facts:
Why in News?
Key Findings of the report:
The six main gases under Kyoto Protocol are:
Why in News?
INTERPOL has launched an app called ‘ID-Art’ to better protect cultural heritage.
About ‘ID-Art’ App:
Key facts:
Why in News?
The Food and Agriculture Organization(FAO) has released the World Food Price Index.
According to the index, world food prices have increased for the 11th consecutive month in April. Further, the prices also hit their highest level since May 2014.
About World Food Price Index:
About Food and Agriculture Organization (FAO)
Why in News?
IIT Madras supported start-up Modulus Housing has developed a portable hospital unit called ‘MediCAB’.
About Project MediCAB:
The project is a decentralized approach to detect, screen, identify, isolate and treat COVID-19 patients in their local communities through these portable microstructures.
Read MoreWhy in News?
The Ministry of Ayush has launched a massive nationwide campaign to distribute two key products. One is the Ayurvedic drug AYUSH 64. The other is the Siddha drug Kabasura Kudineer. Both will provide benefit to the vast majority of out of hospital Covid-19 patients.
About Ayush 64:
About Kabasura Kudineer:
Why in News?
The Drugs Controller General of India recently approved an oral drug to treat COVID-19 called the 2-DG. The 2-DG was developed by the Defense Research Development Organization for Emergency Use. 2-DG is 2-Deoxy – D – Glucose. It was developed in collaboration with Dr Reddy’s Laboratories.
About 2-DG drug
• The drug ensures faster recovery of hospitalised patients and will reduce supplemental oxygen dependence during clinical trials.
• It accumulates in infected cells and stops viral synthesis. This accumulation makes the drug unique.
• The drug comes in a powdered form in sachets. It is consumed orally after dissolving in water.
• It was developed by Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS is a laboratory operating under DRDO.
• The DGCI has granted permission for emergency use of the drug in moderate to severe COVID-19 patients.
• 2-DG is a generic molecule and thus can be easily produced and made available in plenty in the country.
© 2025 Civilstap Himachal Design & Development